Transportation Noise Increases Risk for Suicides (News)
https://www.swisstph.ch/en/news/news-detail/news/transportation-noise-increases-risk-for-suicides
Mental health disorders affect nearly one billion people worldwide and are a leading cause of suicide. In Switzerland, it is estimated that about 1.4 million people are affected by mental health issue
Swiss TPH Symposium on Tuberculosis: A Call to Action (News)
https://www.swisstph.ch/en/news/news-detail/news/swiss-tph-symposium-on-tuberculosis-a-call-to-action
In 2021, an estimated 1.6 million people died of tuberculosis (TB), making it the world’s second deadliest infectious killer, right after COVID-19. The COVID-19 pandemic has further accelerated the pu
Swiss TPH Symposium on Clinical Decision Support Systems (News)
https://www.swisstph.ch/en/news/swiss-tph-symposium-on-clinical-decision-support-systems
Around 150 experts from different organisations and countries met on 8 February for a symposium on clinical decision support (CDSS) in resource-limited settings. The symposium was organised by Swiss T
Pascal Mäser Appointed Full Professor at the University of Basel (News)
https://www.swisstph.ch/en/news/news-detail/news/pascal-maeser-appointed-full-professor-at-the-university-of-basel
Pascal Mäser leads the Parasite Chemotherapy Unit at the Department of Medical Parasitology and Infection Biology (MPI) at Swiss TPH. Mäser’s research focuses on drug discovery for trypanosomatid para
Swiss TPH Symposium: Improving Access to Healthcare in LMICs (News)
https://www.swisstph.ch/en/news/news-detail/news/swiss-tph-symposium-improving-access-to-healthcare-in-lmics
There are manifold challenges which can hinder access to medicines. They range all the way from limited funding for research on neglected diseases, complexity in drug development in resource-limited s
Milestone in the Fight Against Sleeping Sickness (News)
https://www.swisstph.ch/en/news/news-detail/news/milestone-in-the-fight-against-sleeping-sickness
Sanofi, DNDi and the HAT-r-ACC consortium announce the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive scientific opinion of Fexinidazole
Climate Change Weakens Respiratory Health Benefits of Clean Air and Greenspaces (News)
https://www.swisstph.ch/en/news/news-detail/news/climate-change-weakens-respiratory-health-benefits-of-clean-air-and-greenspaces
The research of Swiss TPH and partners explored the associations of long-term exposure to air pollution, greenspaces, and temperature with lung function in children and adults. Drawing on data from mo
Two New Members of the Swiss TPH Board of Governors (News)
https://www.swisstph.ch/en/news/news-detail/news/two-new-members-of-the-swiss-tph-board-of-governors
“We warmly welcome Barbara Wieland and Jacques Fellay, two nationally and internationally recognized experts, to the Swiss TPH Board of Governors,” said Jürg Utzinger, Director of Swiss TPH. “Their va
Treating Schistosomiasis in Pre-School Children (News)
https://www.swisstph.ch/en/news/20170613-treating-schistosomiasis-in-pre-school-children
When left untreated, schistosomiasis can lead to anaemia, stunted growth, severe damage of organs, and - at worst - death. In total, about 258 million people are infected globally, of which about 10%
